{"id":"https://openalex.org/W2103603475","doi":"https://doi.org/10.1186/1756-8722-5-71","title":"A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide","display_name":"A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide","publication_year":2012,"publication_date":"2012-11-29","ids":{"openalex":"https://openalex.org/W2103603475","doi":"https://doi.org/10.1186/1756-8722-5-71","mag":"2103603475","pmid":"https://pubmed.ncbi.nlm.nih.gov/23190430","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3520696"},"language":"en","primary_location":{"id":"doi:10.1186/1756-8722-5-71","doi":"https://doi.org/10.1186/1756-8722-5-71","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1756-8722-5-71","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/1756-8722-5-71","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology & Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/1756-8722-5-71","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038660651","display_name":"Eunice S. Wang","orcid":"https://orcid.org/0000-0002-8644-0968","observed_orcids":["https://orcid.org/0000-0002-8644-0968"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Eunice S Wang","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. eunice.wang@roswellpark.org","Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. eunice.wang@roswellpark.org","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025294989","display_name":"Roger M. Lyons","orcid":"https://orcid.org/0000-0001-6508-8080","observed_orcids":["https://orcid.org/0000-0001-6508-8080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger M Lyons","raw_affiliation_strings":["Cancer Care Centers of South Texas/US Oncology, 4411 Medical Drive, Suite 100, San Antonio, TX, 78229, USA","Cancer Care Centers of South Texas/US Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Care Centers of South Texas/US Oncology, 4411 Medical Drive, Suite 100, San Antonio, TX, 78229, USA","institution_ids":[]},{"raw_affiliation_string":"Cancer Care Centers of South Texas/US Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard A Larson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4390039251","display_name":"University of Chicago Medicine Comprehensive Cancer Center","ror":"https://ror.org/042wftp98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865","https://openalex.org/I4390039251"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A Larson","raw_affiliation_strings":["Comprehensive Cancer Center, University of Chicago, 5841 S. Maryland Avenue, MC-2115, Chicago, Illinois, 60637, USA","University-of Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, University of Chicago, 5841 S. Maryland Avenue, MC-2115, Chicago, Illinois, 60637, USA","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4390039251"]},{"raw_affiliation_string":"University-of Chicago","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039616916","display_name":"Sunil G. Gandhi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sunil Gandhi","raw_affiliation_strings":["Cancer and Blood Disease Center, 421 N. Lecanto Highway, Lecanto, Florida, 34461, USA","Cancer and Blood Disease Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer and Blood Disease Center, 421 N. Lecanto Highway, Lecanto, Florida, 34461, USA","institution_ids":[]},{"raw_affiliation_string":"Cancer and Blood Disease Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052008214","display_name":"Delong Liu","orcid":"https://orcid.org/0000-0003-4502-4949","observed_orcids":["https://orcid.org/0000-0003-4502-4949","https://orcid.org/0000-0001-9956-0857"]},"institutions":[{"id":"https://openalex.org/I1321686444","display_name":"Westchester Medical Center","ror":"https://ror.org/03fcgva33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1321686444"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Delong Liu","raw_affiliation_strings":["Westchester Medical Center, Munger Pavilion 250, Valhalla, New York, 10595, USA","Westchester Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Westchester Medical Center, Munger Pavilion 250, Valhalla, New York, 10595, USA","institution_ids":["https://openalex.org/I1321686444"]},{"raw_affiliation_string":"Westchester Medical Center","institution_ids":["https://openalex.org/I1321686444"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041756354","display_name":"Carmen Matei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140702","display_name":"Rocky Mountain Cancer Centers","ror":"https://ror.org/03ynhs115","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140702"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carmen Matei","raw_affiliation_strings":["Rocky Mountain Cancer Centers/US Oncology, 3027 North Circle Drive, Colorado Springs, CO, 80909, USA","Rocky Mountain Cancer Centers/US Oncology, Colorado Springs, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rocky Mountain Cancer Centers/US Oncology, 3027 North Circle Drive, Colorado Springs, CO, 80909, USA","institution_ids":["https://openalex.org/I4210140702"]},{"raw_affiliation_string":"Rocky Mountain Cancer Centers/US Oncology, Colorado Springs, USA","institution_ids":["https://openalex.org/I4210140702"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629157","display_name":"Bart Lee Scott","orcid":"https://orcid.org/0000-0001-9620-7839","observed_orcids":["https://orcid.org/0000-0001-9620-7839"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bart Scott","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N, D1-100, Seattle, Washington, 98109, USA","Fred Hutchinson Cancer Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N, D1-100, Seattle, Washington, 98109, USA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111468816","display_name":"Kuolung Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kuolung Hu","raw_affiliation_strings":["Amgen Inc., One Amgen Center Drive, Thousand Oaks, California, 91320, USA","Amgen Inc., One Amgen Center Drive, Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., One Amgen Center Drive, Thousand Oaks, California, 91320, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc., One Amgen Center Drive, Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112485671","display_name":"Allen S. Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen S Yang","raw_affiliation_strings":["Amgen Inc., One Amgen Center Drive, Thousand Oaks, California, 91320, USA","Amgen Inc., One Amgen Center Drive, Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., One Amgen Center Drive, Thousand Oaks, California, 91320, USA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Amgen Inc., One Amgen Center Drive, Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5038660651"],"corresponding_institution_ids":["https://openalex.org/I1292894508"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":{"value":4990,"currency":"USD","value_usd":4990},"fwci":5.1073,"has_fulltext":true,"cited_by_count":61,"citation_normalized_percentile":{"value":0.95878045,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"5","issue":"1","first_page":"71","last_page":"71"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.6312999725341797,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.6312999725341797,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.2703000009059906,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.996999979019165},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9909999966621399},{"id":"https://openalex.org/keywords/thrombopoietin-receptor-agonists","display_name":"thrombopoietin receptor agonists","score":0.8629999756813049},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/platelet-transfusion","display_name":"platelet transfusion","score":0.6859999895095825},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.3720000088214874},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.34700000286102295},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia-progression","display_name":"acute myeloid leukemia progression","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C2776915898","wikidata":"https://www.wikidata.org/wiki/Q1235195","display_name":"Romiplostim","level":5,"score":0.9534333944320679},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7672067880630493},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7631784677505493},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6642247438430786},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.577312707901001},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5280036926269531},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5200390815734863},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.4307926893234253},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41233670711517334},{"id":"https://openalex.org/C2777863708","wikidata":"https://www.wikidata.org/wiki/Q424519","display_name":"Thrombopoietin","level":4,"score":0.21632680296897888},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.20998117327690125},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.0},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.0},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077269","descriptor_name":"Lenalidomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013926","descriptor_name":"Thrombopoietin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013926","descriptor_name":"Thrombopoietin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/1756-8722-5-71","doi":"https://doi.org/10.1186/1756-8722-5-71","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1756-8722-5-71","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/1756-8722-5-71","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology & Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2520432","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3520696","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3520696","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3520696","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Hematol Oncol","raw_type":"Text"},{"id":"pmid:23190430","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23190430","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hematology & oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:doaj.org/article:293b587e1b1c4b5ea3d90375f9f4dc31","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/293b587e1b1c4b5ea3d90375f9f4dc31","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Hematology & Oncology, Vol 5, Iss 1, p 71 (2012)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1756-8722-5-71","doi":"https://doi.org/10.1186/1756-8722-5-71","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1756-8722-5-71","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/1756-8722-5-71","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology & Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2103603475.pdf","grobid_xml":"https://content.openalex.org/works/W2103603475.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W187238933","https://openalex.org/W2000252768","https://openalex.org/W2009650262","https://openalex.org/W2028751390","https://openalex.org/W2031574956","https://openalex.org/W2033556677","https://openalex.org/W2036587441","https://openalex.org/W2066053804","https://openalex.org/W2093845572","https://openalex.org/W2096638244","https://openalex.org/W2103020543","https://openalex.org/W2103336749","https://openalex.org/W2114492363","https://openalex.org/W2117418266","https://openalex.org/W2121710010","https://openalex.org/W2122811690","https://openalex.org/W2125438418","https://openalex.org/W2126821957","https://openalex.org/W2129510594","https://openalex.org/W2134292391","https://openalex.org/W2139745353","https://openalex.org/W2556013832","https://openalex.org/W2559983595","https://openalex.org/W2583784450","https://openalex.org/W3135020720","https://openalex.org/W4232645703","https://openalex.org/W4242962945","https://openalex.org/W4245107633"],"related_works":["https://openalex.org/W2550141553","https://openalex.org/W1602160610","https://openalex.org/W2103336749","https://openalex.org/W636520691","https://openalex.org/W2134292391","https://openalex.org/W2028751390","https://openalex.org/W2626757480","https://openalex.org/W7005612551","https://openalex.org/W2588459529","https://openalex.org/W4205154431"],"abstract_inverted_index":{"BACKGROUND:":[0],"Lenalidomide":[1],"treatment":[2,75,197,214,225,281],"in":[3,38,90,94,100,109,117,121,127,136,150,153,158,161,165,171,180,208,246],"myelodysplastic":[4],"syndrome":[5],"(MDS)":[6],"may":[7,282],"lead":[8],"to":[9,49,82,250,259,267,276,290,296],"thrombocytopenia":[10],"and":[11,19,26,106,133,177,239],"dose":[12,287],"reductions/delays.":[13],"This":[14],"study":[15,293],"evaluated":[16],"the":[17,22,30,95,101,110,122,128,137,143,166,172,181,186,224,263,284,298],"safety":[18],"tolerability":[20],"of":[21,32,188,206,265,286,300],"thrombopoietin":[23],"mimetic":[24],"romiplostim":[25,56,102,129,138,173,210,232,274],"its":[27],"effects":[28],"on":[29],"incidence":[31],"clinically":[33],"significant":[34],"thrombocytopenic":[35],"events":[36,222],"(CSTEs)":[37],"lower":[39,149,204],"risk":[40],"MDS":[41,277],"patients":[42,120,164,189,236,278],"receiving":[43],"lenalidomide.":[44],"METHODS:":[45],"Patients":[46],"were":[47,77,88,115,194,217],"assigned":[48],"weekly":[50],"placebo":[51,96,123,167],"(n":[52,59,65],"=":[53,60,66],"12)":[54],"or":[55,62,261],"500":[57,103,130,174,233,238],"\u03bcg":[58,64,104,112,131,140,175,183],"14)":[61],"750":[63,111,139,182,240],"13)":[67],"for":[68],"four":[69],"28-day":[70],"lenalidomide":[71,159,280],"cycles.":[72],"RESULTS:":[73],"The":[74],"groups":[76,211],"generally":[78],"similar":[79,195],"with":[80],"respect":[81],"baseline":[83],"disease":[84],"characteristics.":[85],"Del(5q)":[86],"abnormalities":[87],"noted":[89,116],"1":[91],"(8%)":[92],"patient":[93],"group,":[97,105,124,132,168,176],"3":[98],"(21%)":[99],"two":[107,218],"(15%)":[108,179],"group.":[113,141,184],"CSTEs":[114],"8":[118,134],"(67%)":[119],"4":[125],"(29%)":[126],"(62%)":[135],"Throughout":[142],"study,":[144],"median":[145],"platelet":[146,192],"counts":[147],"trended":[148],"placebo-treated":[151],"than":[152],"romiplostim-treated":[154],"patients.":[155],"Thrombocytopenia-related":[156],"adjustments":[157],"occurred":[160],"6":[162],"(50%)":[163],"5":[169],"(36%)":[170],"2":[178],"Although":[185],"percentages":[187],"who":[190],"received":[191],"transfusions":[193,207],"across":[196],"groups,":[198],"there":[199],"was":[200],"a":[201],"trend":[202],"toward":[203],"numbers":[205],"both":[209],"during":[212,223,252,279],"each":[213],"cycle.":[215],"There":[216],"serious":[219],"treatment-related":[220],"adverse":[221],"period":[226],"(cerebrovascular":[227],"accident,":[228],"placebo;":[229],"worsening":[230],"thrombocytopenia,":[231],"\u03bcg).":[234],"Two":[235],"(romiplostim":[237],"\u03bcg,":[241],"respectively)":[242],"had":[243,255],"an":[244],"increase":[245],"bone":[247],"marrow":[248],"blasts":[249],">20%":[251],"treatment,":[253],"but":[254],"no":[256],"post-treatment":[257],"biopsy":[258],"confirm":[260,297],"exclude":[262],"diagnosis":[264],"progression":[266],"AML.":[268],"CONCLUSIONS:":[269],"These":[270],"data":[271],"suggest":[272],"that":[273],"administered":[275],"decrease":[283],"frequency":[285],"reductions/delays":[288],"due":[289],"thrombocytopenia.":[291],"Additional":[292],"is":[294],"needed":[295],"results":[299],"this":[301],"preliminary":[302],"trial.":[303],"TRIAL":[304],"REGISTRATION:":[305],"ClinicalTrials.gov":[306],"NCT00418665.":[307]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}